Skip to content

The Executives BriefBetaGlobal · Daily

Business Technology Science Politics Entertainment For You

Executive DeskStocks Analyzer

Loading the Newsroom

Curating from trusted global sources…

The Executives Brief

Executive intelligence - curated from trusted global sources and refined into a daily strategic briefing.

Topics

Business
Technology
Science
Politics
Entertainment

Regions

Middle East
Americas
Asia
Europe
Africa

The Brief

About
The Executives Club
Register
RSS
Sitemap

© 2026 The Executives Brief. All rights reserved.Curated by editors · Refined by AI · Owned by readers.

Search results

Search · bristol myers squibb

1 briefing · “bristol myers squibb”

TrendingAstrazeneca Bristol Myers Squibb Pascal Soriot Pharmaceutical Mergers UK Business Cross Border Deals Drug Competition Oncology

FromTo

Showing results for “bristol myers squibb”

AstraZeneca talks a $400bn BMS merger, Pascal Soriot eyes a near-$300bn pharma colossus

Business·Europe

AstraZeneca talks a $400bn BMS merger, Pascal Soriot eyes a near-$300bn pharma colossus

AstraZeneca is understood to be in talks to buy Bristol Myers Squibb, reshaping deal math and regulatory scrutiny at scale.

By Hessa Al-Faleh·11 days ago· 3 min